QDA and QBRI Organize Joint Lecture to Raise Diabetes

HBKU scientists address research into stem cell therapy for diabetes

Entity: Qatar Biomedical Research Institute

QDA and QBRI Organize Joint Lecture to Raise Diabetes Awareness

Qatar Diabetes Association (QDA), member of Qatar Foundation, together with Qatar Biomedical Research Institute (QBRI), part of Hamad Bin Khalifa University (HBKU) organized a lecture for parents of children with type 1 diabetes. The lecture also provided the wider community with an in-depth overview of stem cell research.

The lecture was led by QBRI scientists, Dr. Mohamed Emara, who touched on the subject of the latest advanced research in stem cell technology; and Dr. Essam Abdelalim, who discussed diabetes, stem cells therapy, and the global research being conducted to improve the treatment of the disease.

Dr. Omar El-Agnaf, executive director at QBRI, said: “QBRI’s Diabetes Research Center is fully committed to pursuing novel approaches to tackling diabetes, and especially in light of global forecasts indicating an increase in the number of afflicted patients. QDA is a longstanding partner and we share the objective of securing a healthier future for Qatar by raising awareness and enabling the wider community to seek out advice from established experts in the field, as well as showcase QBRI’s advanced knowledge and research efforts in diabetes.”

Members of the audience, including parents of children with type 1 diabetes, were given an opportunity to raise questions to QBRI’s scientists pertaining to the disease and the latest developments in the stem cell research and potential treatment for their family members using this new technology.

Dr. Abdulla Al Hamaq, executive director at QDA, said: “QDA is committed to running diabetes awareness programs to promote a greater understanding of diabetes, increase prevention, and improve care. We are pleased to collaborate with QBRI in organizing this important lecture, which offered the parents an opportunity to gain a clearer understanding of the valuable research led by QBRI. “

“In addition, we are so pleased that parents of children living with diabetes responded to the abundant and valuable scientific information, which confirms that there is important and promising research underway at QBRI. We are eagerly keeping an eye on the work of QBRI scientists and their efforts to produce pancreatic cells that secrete insulin in laboratories in efficient and large quantities for future use, to replace infected pancreatic cells,” he explained.

QDA QBRI

Dr. Essam M. Abdelalim, scientist at QBRI, said: “The ultimate goal of our stem cell research at QBRI is to pave the way for developing novel therapeutic strategies for diabetes treatment. Our current stem cell projects aim to achieve two main goals, which are understanding genetic factors underlying the development of diabetes using induced pluripotent stem cell technology, and generation of functional insulin-secreting beta cells for cell therapy.“

Dr. Mohamed Emara, scientist at QBRI, said: “Using stem cells as a therapeutic tool to treat different diseases is very promising. Currently, there are several clinical trials taking place around the world to test the cure with such new technology. Patients with diabetes, Parkinson’s, Alzheimer’s, and other chronic diseases have to know that there is still hope for a complete cure. Stem cell therapy is at the forefront of our efforts and we are looking to conduct research that resonates locally, regionally and globally.”

QBRI is home to three research centers – Cancer Research Center, Diabetes Research Center, and the Neurological Disorders Research Center. The Diabetes Research Center serves as a catalyst to promote innovative research on both type 1 and type 2 diabetes and related metabolic disorders, with the aim of gaining fundamental knowledge to enhance the understanding of social, molecular, and genetic causes of the disease.

QDA and QBRI Organize Joint Lecture to Raise Diabetes Awareness

HBKU scientists address research into stem cell therapy for diabetes

Share:

Related News

QDA and QBRI Organize Joint Lecture to Raise Diabetes Awareness

HBKU scientists address research into stem cell therapy for diabetes

Share:

Related News

QBRI Partners with PHCC and QCRI to Combat Prediabetes Through New Screening Tool

HBKU’s QBRI Concludes 8th Edition of Summer Research Program

HBKU’s QBRI Wraps Up Autism Awareness Activities

QBRI and Sultan Qaboos University Collaborate on Autism Spectrum Disorder Research

HBKU's QBRI Unveils Promising Arabic Stimuli: A Step Forward in Autism Spectrum Disorder (ASD) Diagnosis

HBKU’s QBRI Opens Applications for 2024 Summer Research Program

HBKU’s QBRI Conducts an Important Study of Cancer Trends in Arab Countries

HBKU’s QBRI Refutes Consanguinity as Risk Factor for Autism

Unveiling New Insights into Dementia: Autoantibodies and Blood-Based Biomarkers

QBRI's Blood Protein Biomarker Study Sheds Light on Autism Spectrum Disorder

Embracing the Colors of the Autism Spectrum: The Importance of Early Intervention and Advocacy

QBRI Highlights Diabetes Research Center in 2022 – A Year in Review

QBRI Tackles Genome-Related Complexities in Triple Negative Breast Cancer

QBRI Meets With Its Scientific Advisory Committee

QBRI Hosts Inaugural Research in Focus Event

QBRI Online Seminar to Promote Research Visibility

100-Year Anniversary of the Discovery of Insulin is of Great Relevance to QBRI

Qatar Biomedical Research Institute and Qatar University Scientists Conclude the International Symposium on Role of Glycation in Food-Health-Disease

QBRI Concludes Alzheimer’s Disease Month Awareness Campaign

QBRI Joins Hands with Qatar University to Provide Research Analytical Services

QBRI Partners with PHCC and QCRI to Combat Prediabetes Through New Screening Tool

HBKU’s QBRI Concludes 8th Edition of Summer Research Program

HBKU’s QBRI Wraps Up Autism Awareness Activities

QBRI and Sultan Qaboos University Collaborate on Autism Spectrum Disorder Research

HBKU's QBRI Unveils Promising Arabic Stimuli: A Step Forward in Autism Spectrum Disorder (ASD) Diagnosis

HBKU’s QBRI Opens Applications for 2024 Summer Research Program

HBKU’s QBRI Conducts an Important Study of Cancer Trends in Arab Countries

HBKU’s QBRI Refutes Consanguinity as Risk Factor for Autism

Unveiling New Insights into Dementia: Autoantibodies and Blood-Based Biomarkers

QBRI's Blood Protein Biomarker Study Sheds Light on Autism Spectrum Disorder

Embracing the Colors of the Autism Spectrum: The Importance of Early Intervention and Advocacy

QBRI Highlights Diabetes Research Center in 2022 – A Year in Review

QBRI Tackles Genome-Related Complexities in Triple Negative Breast Cancer

QBRI Meets With Its Scientific Advisory Committee

QBRI Hosts Inaugural Research in Focus Event

QBRI Online Seminar to Promote Research Visibility

100-Year Anniversary of the Discovery of Insulin is of Great Relevance to QBRI

Qatar Biomedical Research Institute and Qatar University Scientists Conclude the International Symposium on Role of Glycation in Food-Health-Disease

QBRI Concludes Alzheimer’s Disease Month Awareness Campaign

QBRI Joins Hands with Qatar University to Provide Research Analytical Services

QBRI Partners with PHCC and QCRI to Combat Prediabetes Through New Screening Tool

HBKU’s QBRI Concludes 8th Edition of Summer Research Program

HBKU’s QBRI Wraps Up Autism Awareness Activities

QBRI and Sultan Qaboos University Collaborate on Autism Spectrum Disorder Research

HBKU's QBRI Unveils Promising Arabic Stimuli: A Step Forward in Autism Spectrum Disorder (ASD) Diagnosis

HBKU’s QBRI Opens Applications for 2024 Summer Research Program

HBKU’s QBRI Conducts an Important Study of Cancer Trends in Arab Countries

HBKU’s QBRI Refutes Consanguinity as Risk Factor for Autism

Unveiling New Insights into Dementia: Autoantibodies and Blood-Based Biomarkers

QBRI's Blood Protein Biomarker Study Sheds Light on Autism Spectrum Disorder

Embracing the Colors of the Autism Spectrum: The Importance of Early Intervention and Advocacy

QBRI Highlights Diabetes Research Center in 2022 – A Year in Review

QBRI Tackles Genome-Related Complexities in Triple Negative Breast Cancer

QBRI Meets With Its Scientific Advisory Committee

QBRI Hosts Inaugural Research in Focus Event

QBRI Online Seminar to Promote Research Visibility

100-Year Anniversary of the Discovery of Insulin is of Great Relevance to QBRI

Qatar Biomedical Research Institute and Qatar University Scientists Conclude the International Symposium on Role of Glycation in Food-Health-Disease

QBRI Concludes Alzheimer’s Disease Month Awareness Campaign

QBRI Joins Hands with Qatar University to Provide Research Analytical Services

QBRI Partners with PHCC and QCRI to Combat Prediabetes Through New Screening Tool

HBKU’s QBRI Concludes 8th Edition of Summer Research Program

HBKU’s QBRI Wraps Up Autism Awareness Activities

QBRI and Sultan Qaboos University Collaborate on Autism Spectrum Disorder Research

HBKU's QBRI Unveils Promising Arabic Stimuli: A Step Forward in Autism Spectrum Disorder (ASD) Diagnosis

HBKU’s QBRI Opens Applications for 2024 Summer Research Program

HBKU’s QBRI Conducts an Important Study of Cancer Trends in Arab Countries

HBKU’s QBRI Refutes Consanguinity as Risk Factor for Autism

Unveiling New Insights into Dementia: Autoantibodies and Blood-Based Biomarkers

QBRI's Blood Protein Biomarker Study Sheds Light on Autism Spectrum Disorder

Embracing the Colors of the Autism Spectrum: The Importance of Early Intervention and Advocacy

QBRI Highlights Diabetes Research Center in 2022 – A Year in Review

QBRI Tackles Genome-Related Complexities in Triple Negative Breast Cancer

QBRI Meets With Its Scientific Advisory Committee

QBRI Hosts Inaugural Research in Focus Event

QBRI Online Seminar to Promote Research Visibility